Companion Diagnostics for Targeted Cancer Drugs €“ Clinical and Regulatory Aspects

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2014.00105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Companion Diagnostics and Molecular Imaging-Enhanced Approaches for Oncology Clinical Trials

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection

Cancer Research
Cancer ResearchOncology
2017English

The Evolving Role of Companion Diagnostics for Breast Cancer in an Era of Next-Generation Omics

American Journal of Pathology
Forensic MedicinePathology
2017English

Clinical Guidelines for Diagnostics, Treatment and Monitoring of Patients With Kidney Cancer

Lijecnicki Vjesnik
Medicine
2019English

Clinical Guidelines for Diagnostics, Treatment and Monitoring of Patients With Testicular Cancer

Lijecnicki Vjesnik
Medicine
2019English

Navigating the Rapids: The Development of Regulated Next-Generation Sequencing-Based Clinical Trial Assays and Companion Diagnostics

Frontiers in Oncology
Cancer ResearchOncology
2014English

Clinical Chemistry Companion

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1979English

MET Targeted Therapy for Lung Cancer: Clinical Development and Future Directions

Lung Cancer: Targets and Therapy
Oncology
2012English

Microbiome-Based Companion Diagnostics: No Longer Science Fiction?

Gut
Gastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy